×

Error message

User error: Failed to find file public://video-overlay.png. in imagecache_actions_image_load() (line 104 of /var/www/medical/public_html/sites/all/modules/imagecache_actions/utility.inc).

Heart Failure

University of Utah, Frank Sachse, heart failure, LVAD implantation, left ventricular assist device, biomarker, t-system

Two patients may seem equally sick based upon clinical measures, but differences in their heart physiology could predict who has the potential to recover from heart failure. A study carried out by scientists at the University of Utah finds that patients whose hearts have flattened t-tubules have a decreased chance of showing signs of recovery after implanting a mechanical heart pump. Ordinarily, t-tubules in the heart are long, thin, and rounded. Image courtesy of Frank Sachse.

News | Cardiac Diagnostics | January 17, 2017

January 17, 2017 — Investigators at the University of Utah have identified distinct differences in the hearts of...

Syncardiac Freedom Driver, FDA
News | Artificial Heart | October 26, 2016

October 26, 2016 — The U.S. Food and Drug Administration (FDA) provided an update and additional information...

SJM, st. Jude Medical, FDA recall, Battery depletion, Recalls ICDs and CRT-D
Feature | Implantable Cardioverter Defibrillators (ICD) | October 25, 2016 | Dave Fornell

October 25, 2016 — St. Jude Medical is recalling 251,346 of its Fortify, Unify and Assura implantable cardioverter...

News | Renal Denervation | October 11, 2016

October 11, 2016 — Awards from the National Institutes of Health’s Common Fund are supporting research on the...

Heartware HVAD, ventricular assist device, artificial heart, Medtronic
News | October 05, 2016

October 5, 2016 — Medtronic said two previously communicated global voluntary recalls related to the HeartWare...

CardioKinetix, Parachute device, Heart Failure device therapy

The CardioKinetix Parachute device implant shown deployed in the left ventricle of a heart failure patient. The device helps remodel the ventricle to improve the heart's ability to pump blood more efficiently. 

Feature | Heart Failure | September 29, 2016 | Abha Mishra

New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with...

Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure | September 20, 2016

September 20, 2016 — Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to...

EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT) | September 15, 2016

September 15, 2016 — EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an...

SynCardia, Chapter 11 reorganization, sale, Total Artificial Heart
News | Artificial Heart | September 13, 2016

August 29, 2016 — SynCardia Systems, manufacturer of the...

Carmat, bioprosthetic artificial heart, PIVOTAL study, first implantation, heart failure
News | Artificial Heart | September 09, 2016

September 9, 2016 — Carmat announced that the first implantation of its bioprosthetic...

Videos | Heart Failure | September 02, 2016

The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by...

Respicardia, Remede, pacemaker for sleep apnea, central sleep apnea treatment

The Respicardia Remede System is a pacemaker-like implantable device designed to improve cardiovascular health by restoring natural breathing during sleep in patients with central sleep apnea.

News | Heart Failure | September 02, 2016

September 2, 2016 — Results from an international, randomized study show that an implanted nerve stimulator...

News | Heart Failure | August 23, 2016

August 23, 2016 — A new study of more than 13,000 people has found that so-called morbid obesity appears to stand...

Jason Burdick, injectable hydrogels, heart failure, heart attack, American Chemical Society

Compared to other types of hydrogels being developed (left), a new hydrogel (right) can form crosslinks after injection into the heart, making the material stiffer and longer-lasting. Image courtesy of American Chemical Society.

News | Heart Failure | August 23, 2016

August 23, 2016 — During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells...

Carew Medical Wear, Rod Carew, undergarments, LVAD, HeartMate II, American Heart Association
News | Ventricular Assist Devices (VAD) | August 11, 2016

August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in...

Overlay Init